Actualités réglementaires
10 sept. 2026•1 min de lecture
FDA Lists Watson Labs' COBAVITE Injection (ANDA083064) as Discontinued
FDA records indicate that Watson Labs' injectable product COBAVITE, containing 1 mg/mL cyanocobalamin, is listed as discontinued under ANDA083064.
Actualités réglementaires
8 sept. 2026•1 min de lecture
FDA Approves ANDA083022 for DODEX Injectable (Cyanocobalamin)
The FDA approved ANDA083022 for the DODEX injectable containing 1 mg/mL cyanocobalamin. The product is listed as discontinued.
1
Actualités réglementaires
2 sept. 2026•1 min de lecture
FDA Approves Lupin’s CYANOCOBALAMIN Nasal Spray
The FDA granted approval for Lupin Pharmaceuticals' prescription nasal spray containing 0.5 mg per spray of CYANOCOBALAMIN under ANDA210629.
1